This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2009 Feb 17;150(4):282; author reply 282-3.

doi: 10.7326/0003-4819-150-4-200902170-00018.

Can the SMART study data be used to assess risk factors for renal disease?

PMID: 19221385
DOI: 10.7326/0003-4819-150-4-200902170-00018

Comment

Can the SMART study data be used to assess risk factors for renal disease?

Samir K Gupta. Ann Intern Med. 2009.

. 2009 Feb 17;150(4):282; author reply 282-3.

doi: 10.7326/0003-4819-150-4-200902170-00018.

Author

PMID: 19221385
DOI: 10.7326/0003-4819-150-4-200902170-00018

No abstract available

PubMed Disclaimer

Comment on

Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: a randomized trial.
SMART Study Group; El-Sadr WM, Grund B, Neuhaus J, Babiker A, Cohen CJ, Darbyshire J, Emery S, Lundgren JD, Phillips A, Neaton JD. SMART Study Group, et al. Ann Intern Med. 2008 Sep 2;149(5):289-99. doi: 10.7326/0003-4819-149-5-200809020-00003. Ann Intern Med. 2008. PMID: 18765698 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information